Extrawell Pharmaceutical Holdings Limited (HK:0858) has released an update.
Extrawell Pharmaceutical Holdings Limited has announced the redesignation of Dr. Guo Yi from an independent non-executive director to an executive director, and the appointment of Dr. Zeng Li as a new independent non-executive director, effective 7th June 2024. Both directors bring extensive experience in biotech and genetics, with Dr. Guo also having investment management expertise, while Dr. Zeng has a background in operation management and investment in related fields.
For further insights into HK:0858 stock, check out TipRanks’ Stock Analysis page.
